ImmunityBio, Inc.
DE ˙ DB ˙ US45256X1037
6,13 € ↓ -0,20 (-3,16%)
2026-06-05
DEL PRIS
SecurityDE:26CA / ImmunityBio, Inc.
InstitutionPrincipal Financial Group Inc
Latest Disclosed Ownership19,710 shares
Latest Disclosed Value $ 151,175
Principal Financial Group Inc reports 18.31% increase in ownership of 26CA / ImmunityBio, Inc.

On May 4, 2026 - Principal Financial Group Inc filed a 13F-HR form disclosing ownership of 19,710 shares of ImmunityBio, Inc. (DE:26CA) valued at $129,298 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 16,660 shares of ImmunityBio, Inc.. This represents a change in shares of 18.31% during the quarter. The current value of the position is $120,822 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-04 2026-03-31 13F IMMUNITYBIO COM 45256X103 19,710 3,050 18.31 151 371.88 0.0001
2026-02-02 2025-12-31 13F IMMUNITYBIO COM 45256X103 16,660 -750 -4.31 33 -23.81 0.0000
2025-11-04 2025-09-30 13F IMMUNITYBIO COM 45256X103 17,410 1,157 7.12 43 0.00 0.0000
2025-08-08 2025-06-30 13F IMMUNITYBIO COM 45256X103 16,253 4,832 42.31 43 23.53 0.0000
2025-04-28 2025-03-31 13F IMMUNITYBIO COM 45256X103 11,421 -172 -1.48 34 17.24 0.0000
2025-01-31 2024-12-31 13F IMMUNITYBIO COM 45256X103 11,593 -920 -7.35 30 -36.96 0.0000
2024-10-31 2024-09-30 13F IMMUNITYBIO COM 45256X103 12,513 -28,706 -69.64 47 -82.31 0.0000
2024-07-29 2024-06-30 13F IMMUNITYBIO COM 45256X103 41,219 -32,247 -43.89 261 -34.01 0.0002
2024-04-29 2024-03-31 13F IMMUNITYBIO COM 45256X103 73,466 -2,818 -3.69 395 3.14 0.0002
2024-02-07 2023-12-31 13F IMMUNITYBIO COM 45256X103 76,284 64 0.08 383 198.44 0.0002
2023-11-02 2023-09-30 13F IMMUNITYBIO COM 45256X103 76,220 2,166 2.92 129 -37.56 0.0001
2023-08-07 2023-06-30 13F IMMUNITYBIO COM 45256X103 74,054 9,246 14.27 206 75.21 0.0001
2023-05-09 2023-03-31 13F IMMUNITYBIO COM 45256X103 64,808 -4,164 -6.04 118 -66.48 0.0001
2023-02-09 2022-12-31 13F IMMUNITYBIO COM 45256X103 68,972 11,801 20.64 350 22.46 0.0003
2022-11-09 2022-09-30 13F IMMUNITYBIO COM 45256X103 57,171 1,678 3.02 285 38.35 0.0002
2022-08-10 2022-06-30 13F IMMUNITYBIO COM 45256X103 55,493 9,925 21.78 206 -19.53 0.0002
2022-05-09 2022-03-31 13F IMMUNITYBIO COM 45256X103 45,568 -1,248 -2.67 256 -10.18 0.0001
2022-02-09 2021-12-31 13F IMMUNITYBIO COM 45256X103 46,816 25,163 116.21 285 35.07 0.0002
2021-11-09 2021-09-30 13F IMMUNITYBIO COM 45256X103 21,653 -3,510 -13.95 211 -41.23 0.0001
2021-08-10 2021-06-30 13F IMMUNITYBIO COM 45256X103 25,163 1,173 4.89 359 -37.02 0.0002
2021-05-24 2021-03-31 13F/A-1 IMMUNITYBIO COM 45256X103 23,990 1,690 7.58 570 91.92 0.1505
2021-02-23 2020-12-31 13F/A-1 NANTKWEST COM 63016Q102 22,300 2,284 11.41 297 113.67 0.0002
2021-02-08 2020-12-31 13F NANTKWEST COM 63016Q102 22,300 2,284 297 116.8444
2020-11-06 2020-09-30 13F NANTKWEST COM 63016Q102 20,016 -990 -4.71 139 -46.12 0.0001
2020-08-05 2020-06-30 13F NANTKWEST COM 63016Q102 21,006 21,006 258 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.